Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
about
The mode of action of anticancer gold-based drugs: a structural perspectiveInteractions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compoundInteractions of gold-based drugs with proteins: the structure and stability of the adduct formed in the reaction between lysozyme and the cytotoxic gold(III) compound Auoxo3Novel amphiphilic cationic porphyrin and its Ag(II) complex as potential anticancer agents.Luminescent cyclometallated iridium(III) bis(quinolylbenzaldehyde) diimine complexes--synthesis, photophysics, electrochemistry, protein cross-linking properties, cytotoxicity and cellular uptake.Gold ion-angiotensin peptide interaction by mass spectrometry.Synthesis and anti-cancer activities of a water soluble gold(III) porphyrin.Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60.Gold(III) macrocycles: nucleotide-specific unconventional catalytic inhibitors of human topoisomerase I.Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment.Gold complexes as antimicrobial agents: an overview of different biological activities in relation to the oxidation state of the gold ion and the ligand structure.Chemical biology of anticancer gold(III) and gold(I) complexes.The gold (III) porphyrin complex, gold-2a, suppresses WNT1 expression in breast cancer cells by enhancing the promoter association of YY1.Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication.(Metallo)porphyrins as potent phototoxic anti-cancer agents after irradiation with red light.A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex.Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.[Au2(phen(2Me))2(μ-O)2](PF6)2, a Novel Dinuclear Gold(III) Complex Showing Excellent Antiproliferative Properties.A gold(III) porphyrin complex as an anti-cancer candidate to inhibit growth of cancer-stem cells.Organogold(III) supramolecular polymers for anticancer treatment.A dual cytotoxic and anti-angiogenic water-soluble gold(III) complex induces endoplasmic reticulum damage in HeLa cells.Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine.Luminescent rhenium(I) polypyridine complexes appended with an α-D-glucose moiety as novel biomolecular and cellular probes.Water-soluble Manganese and Iron Mesotetrakis(carboxyl)porphyrin: DNA Binding, Oxidative Cleavage, and Cytotoxic Activities.Near Infrared Phosphorescent, Non-oxidizable Palladium and Platinum Perfluoro-phthalocyanines.Pincer-Type Platinum(II) Complexes Containing N-Heterocyclic Carbene (NHC) Ligand: Structures, Photophysical and Anion-Binding Properties, and Anticancer Activities.DNA molecular recognition and cellular selectivity of anticancer metal(II) complexes of ethylenediaminediacetate and phenanthroline: multiple targets.Gold(iii) tetraarylporphyrin amino acid derivatives: ligand or metal centred redox chemistry?† †Electronic supplementary information (ESI) available: NMR and IR spectra, spectral changes upon reduction of [Au(TPP)][PF6], [4a][PF6], [4b][PF6], [4c][PGold(iii) complexes inhibit growth of cisplatin-resistant ovarian cancer in association with upregulation of proapoptotic PMS2 geneA dinuclear cyclometalated gold(iii)–phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo
P2860
Q27686705-FE6CD494-2082-45B3-A2DF-8A0146B40B3AQ27687736-55CD89C9-BEDB-4C66-84BF-280980F0D7F0Q27695726-639E97C0-2DAB-40BA-9B36-262A5149C0D0Q30660258-1D568FE3-C1B6-46A7-B8F3-9D4B66EB49A9Q33662101-8C46272E-36C3-4128-A709-8D85D55DCF8FQ34164962-402F82B8-3F95-4D88-B546-67A1D07C5F7DQ35530076-7A44BD02-694A-414B-BB18-EBF5035AA71AQ35867952-FA458B74-3C40-4818-91CD-F65F71472E6EQ37731572-844ECF7C-F393-4093-B198-9E743F68A255Q37889670-0F4071CF-A02F-4844-86FE-A97A3F05AC09Q38193658-8A5C21D7-0F53-4BBA-8DC7-E08829D3494EQ38418786-825DE246-5019-44CA-A332-C9C20CB242BBQ38880669-71B61CAA-9993-4A5C-A00C-DD31BBE328D1Q38883131-2B10EF36-4C0B-4088-8CD4-7FE312887480Q38938042-C9047CE0-94E7-4A56-BFCE-6FAC544ACD02Q38956634-7A2A4DD6-602A-4209-847C-6F6987612E4DQ38962540-CA02A667-698E-4FE9-83C4-F7182FBA20E2Q39159067-76E48230-E692-488F-8E8D-C12FDF366F80Q39230008-7C65B6FB-7BCC-484B-B252-D1E89C750AF0Q39369795-6EE9FC3F-BF64-4A0D-9D2F-2AAD0F58989DQ39388730-4655FD17-2777-49BB-9D2F-15E62C2B7D96Q39465410-13E8D93A-AE97-44C1-A44A-949EF9452E4EQ39516201-9D35C366-E1A9-4B5A-B5DA-4E79A521D220Q47975081-935AB456-7540-4ED8-826C-58C26935BDFBQ48252902-6D4A7FD0-0613-4D35-AEBA-7D023B220B51Q50437449-B65192B0-C9B0-43A2-B5BD-3419C8D6D29DQ53226568-2DE63576-C3AD-4501-A249-4B5C8E99C6B7Q55024521-17C2E98A-1119-41F7-BDF7-4494083FD5ACQ58921526-FC188CAE-B2C1-4A9F-A4DD-DDA1B7660B75Q58921543-AD00809B-D41B-4E9E-A8CA-370ABFE2EA8F
P2860
Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Stable anticancer gold
@nl
Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
@en
type
label
Stable anticancer gold
@nl
Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
@en
prefLabel
Stable anticancer gold
@nl
Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
@en
P2093
P50
P356
P1476
Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
@en
P2093
Carrie Ka-Lei Li
Chun-Nam Lok
Jessie Jing Yan
Nianyong Zhu
Raymond Wai-Yin Sun
P304
P356
10.1002/CHEM.200902741
P407
P577
2010-03-01T00:00:00Z